4//SEC Filing
Elrod James W 4
Accession 0001209191-10-018041
CIK 0001047699other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 5:07 PM ET
Size
7.7 KB
Accession
0001209191-10-018041
Insider Transaction Report
Form 4
Elrod James W
Chief Legal Officer, Secretary
Transactions
- Award
Stock Option (Right to Buy)
2010-03-17+45,540→ 45,540 totalExercise: $12.44Exp: 2020-03-17→ Common Stock (45,540 underlying) - Award
Common Stock
2010-03-17+12,900→ 187,445 total
Footnotes (2)
- [F1]The reported transaction represents restricted stock that was granted on March 17, 2010, pursuant to King Pharmaceuticals, Inc. Long Term Incentive Award program. One hundred percent of such stock vests on March 17, 2013.
- [F2]Thirty-three percent of this stock option, which was granted under the King Pharmaceuticals, Inc. Long Term Incentive Award program, will vest on March 17, 2011; 33% of the stock option will vest on March 17, 2012; and the remaining 34% of the stock option will vest on March 17, 2013.
Documents
Issuer
KING PHARMACEUTICALS INC
CIK 0001047699
Entity typeother
Related Parties
1- filerCIK 0001354792
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 5:07 PM ET
- Size
- 7.7 KB